Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-positive Breast Cancer × tucatinib × Clear all

Status

Sponsor Class

Study Type

Interventional 3 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1 Breast Neoplasms 1

Interventions

pyrotinib 4 neratinib 2 tucatinib 1 trastuzumab deruxtecan 1 pertuzumab 1 Trastuzumab 1 Hospital Information Systems 1 Genetic Testing 1 Electronic Health Records 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253911 2025-12-04

TRACE

iOMEDICO AG

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡